Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces

The second Expanded Access patient (EA2) demonstrated additional clinical improvement in the Expanded Disability Status Scale (EDSS), a FDA recognized standard clinical outcome assessment score NEW

Related Keywords

, Irina Koffler , Hana Malik , Howardl Weiner , Gabriele Cerrone , Tanuja Chitnis , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Drug Administration , Ann Romney Center , Nasdaq , Business Development , Expanded Access , Expanded Disability Status Scale , Life Sciences , Neurologic Diseases , Scientific Advisory Board , Executive Chairman , Chief Executive Officer , Investor Relations , Sci Advisors , Tiziana , Life , Ciences , Nnounces , Dditional , Linical , Improvements , Second , Patient , Ctive , Secondary , Progressive , Multiple , Clerosis , Pms , After , Eleven , Months , Closing , Intranasal , Foralumab ,